Clustered mutations in hominid genome evolution are consistent with APOBEC3G enzymatic activity

Genome Research

Volumn 26, Issue 5, 2016, Pages 579-587

  Pinto, Yishay ^a   Gabay, Orshay ^a   Arbiza, Leonardo ^b   Sams, Aaron J ^b   Keinan, Alon ^b   Levanon, Erez Y ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b Program on Infrastructure Policy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; APOBEC3G PROTEIN, HUMAN;

ARTICLE; CLUSTERED MUTATION; CONTROLLED STUDY; ENZYME ACTIVITY; EVOLUTION; GENE MUTATION; GENOME; GERMLINE MUTATION; HOMINID; MAMMALIAN GENETICS; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; PHYLOGENETIC TREE; POINT MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION; ANIMAL; GENETICS; HUMAN; MOLECULAR EVOLUTION; MUTATION;

ANIMALS; APOBEC-3G DEAMINASE; EVOLUTION, MOLECULAR; HOMINIDAE; HUMANS; MUTATION;

EID: 84964931472     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.199240.115     Document Type: Article

References (57)

1. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SAJR, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Børresen-Dale A-L, et al. 2013. Signatures of mutational processes in human cancer. Nature 500: 415-421.
2. Armitage AE, Deforche K, Welch JJ, Van Laethem K, Camacho R, Rambaut A, Iversen AKN. 2014. Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections. J Virol 88: 12882-12894.
3. Bird AP. 1980. DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res 8: 1499-1504.
4. Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N, Nikas JB, et al. 2013a. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494: 366-370.
5. Burns MB, Temiz NA, Harris RS. 2013b. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet 45: 977-983.
6. Campbell CD, Eichler EE. 2013. Properties and rates of germline mutations in humans. Trends Genet 29: 575-584.
7. Carmi S, Church GM, Levanon EY. 2011. Large-scale DNA editing of retrotransposons accelerates mammalian genome evolution. Nat Commun 2: 519.
8. Caval V, Suspène R, Vartanian J-P, Wain-Hobson S. 2014. Orthologous mammalian APOBEC3A cytidine deaminases hypermutate nuclear DNA. Mol Biol Evol 31: 330-340.
9. Chelico L, Pham P, Calabrese P, Goodman MF. 2006. APOBEC3G DNA deaminase acts processively 3' → 5' on single-stranded DNA. Nat Struct Mol Biol 13: 392-399.
10. Chiu Y-L, Greene WC. 2008. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol 26: 317-353.
11. Conticello SG. 2008. The AID/APOBEC family of nucleic acid mutators. Genome Biol 9: 229.
12. Depboylu C, Eiden LE, Weihe E. 2007. Increased APOBEC3G expression is associated with extensive G-to-A hypermutation in viral DNA in rhesus macaque brain during lentiviral infection. J Neuropathol Exp Neurol 66: 901-912.
13. Griffith OL, Montgomery SB, Bernier B, Chu B, Kasaian K, Aerts S, Mahony S, Sleumer MC, Bilenky M, Haeussler M, et al. 2007. ORegAnno: an open-access community-driven resource for regulatory annotation. Nucleic Acids Res 36: D107-D113.
14. Harris K, Nielsen R. 2014. Error-prone polymerase activity causes multinucleotide mutations in humans. Genome Res 24: 1445-1454.
15. Harris RS, Petersen-Mahrt SK, Neuberger MS. 2002. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol Cell 10: 1247-1253.
16. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, Neuberger MS, Malim MH. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809.
17. Henderson S, Chakravarthy A, Su X, Boshoff C, Fenton TR. 2014. APOBECmediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development. Cell Rep 7: 1833-1841.
18. Hill MS, Mulcahy ER, Gomez ML, Pacyniak E, Berman NEJ, Stephens EB. 2006. APOBEC3G expression is restricted to neurons in the brains of pigtailed macaques. AIDS Res Hum Retroviruses 22: 541-550.
19. Hodgkinson A, Eyre-Walker A. 2011. Variation in the mutation rate across mammalian genomes. Nat Rev Genet 12: 756-766.
20. Hultquist JF, Lengyel JA, Refsland EW, LaRue RS, Lackey L, Brown WL, Harris RS. 2011. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J Virol 85: 11220-11234.
21. Jaszczur M, Bertram JG, Pham P, Scharff MD, Goodman MF. 2013. AID and Apobec3G haphazard deamination and mutational diversity. Cell Mol Life Sci 70: 3089-3108.
22. Jurka J. 2000. Repbase Update: a database and an electronic journal of repetitive elements. Trends Genet 16: 418-420.
23. Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D, Kent WJ. 2004. The UCSC Table Browser data retrieval tool. Nucleic Acids Res 32: D493-D496.
24. Keane TM, Goodstadt L, Danecek P, White MA, Wong K, Yalcin B, Heger A, Agam A, Slater G, Goodson M, et al. 2011. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 477: 289-294.
25. Keinan A, Mullikin JC, Patterson N, Reich D. 2007. Measurement of the human allele frequency spectrumdemonstrates greater genetic drift in East Asians than in Europeans. Nat Genet 39: 1251-1255.
26. Kent WJ, SugnetCW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler AD. 2002. The human genome browser at UCSC. Genome Res 12: 996-1006.
27. Kinomoto M, Kanno T, Shimura M, Ishizaka Y, Kojima A, Kurata T, Sata T, Tokunaga K. 2007. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res 35: 2955-2964.
28. Knisbacher BA, Levanon EY. 2016. DNA editing of LTR retrotransposons reveals the impact of APOBECs on vertebrate genomes. Mol Biol Evol 33: 554-567.
29. Koning FA, Newman ENC, Kim E-Y, Kunstman KJ, Wolinsky SM, Malim MH. 2009. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol 83: 9474-9485.
30. Kunsch HR. 1989. The jackknife and the bootstrap for general stationary observations. Ann Stat 17: 1217-1241.
31. Lahiri SN. 2003. Resampling methods for dependent data. Springer, New York.
32. Liddament MT, Brown WL, Schumacher AJ, Harris RS. 2004. APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr Biol 14: 1385-1391.
33. Liu R, Singh K. 1992. Moving blocks jackknife and bootstrap capture weak dependence. In Exploring the limits of bootstrap (ed. LePage R, Billard L), pp. 225-248. John Wiley, New York.
34. Meyer M, Kircher M, Gansauge M-T, Li H, Racimo F, Mallick S, Schraiber JG, Jay F, Prüfer K, de Filippo C, et al. 2012. A high-coverage genome sequence from an archaic Denisovan individual. Science 338: 222-226.
35. Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, et al. 2012. Mutational processes molding the genomes of 21 breast cancers. Cell 149: 979-993.
36. Nowarski R, Wilner OI, Cheshin O, Shahar OD, Kenig E, Baraz L, Britan- Rosich E, Nagler A, Harris RS, Goldberg M, et al. 2012. APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase- dependent DNA repair. Blood 120: 366-375.
37. Prüfer K, Racimo F, Patterson N, Jay F, Sankararaman S, Sawyer S, Heinze A, Renaud G, Sudmant PH, de Filippo C, et al. 2014. The complete genome sequence of a Neanderthal from the Altai Mountains. Nature 505: 43-49.
38. Quinlan AR, Hall IM. 2010. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26: 841-842.
39. Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS. 2010. Quantitative profiling of the full APOBEC3mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res 38: 4274-4284.
40. Roberts SA, Sterling J, Thompson C, Harris S, Mav D, Shah R, Klimczak LJ, Kryukov GV, Malc E, Mieczkowski PA, et al. 2012. Clustered mutations in yeast and in human cancers can arise from damaged long singlestrand DNA regions. Mol Cell 46: 424-435.
41. Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P, Kiezun A, Kryukov GV, Carter SL, Saksena G, et al. 2013. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet 45: 970-976.
42. Rosenbloom KR, Sloan CA, Malladi VS, Dreszer TR, Learned K, Kirkup VM, WongMC, Maddren M, Fang R, Heitner SG, et al. 2013. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res 41: D56-D63.
43. Saraconi G, Severi F, Sala C, Mattiuz G, Conticello SG. 2014. The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas. Genome Biol 15: 417.
44. Sawyer SL, Emerman M, Malik HS. 2004. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol 2: E275.
45. Schumacher AJ, Nissley DV, Harris RS. 2005. APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. Proc Natl Acad Sci 102: 9854-9859.
46. Ségurel L, Wyman MJ, Przeworski M. 2014. Determinants of mutation rate variation in the human germline. Annu Rev Genomics Hum Genet 15: 47-70.
47. Shen HM, Storb U. 2004. Activation-induced cytidine deaminase (AID) can target both DNA strands when the DNA is supercoiled. Proc Natl Acad Sci 101: 12997-13002.
48. Simpson AG. 1997. The natural somatic mutation frequency and human carcinogenesis. Adv Cancer Res 71: 209-240.
49. Stopak K, de Noronha C, YonemotoW, Greene WC. 2003. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell 12: 591-601.
50. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, et al. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci 101: 6062-6067.
51. Suspène R, Aynaud M-M, Guétard D, Henry M, Eckhoff G, Marchio A, Pineau P, Dejean A, Vartanian J-P, Wain-Hobson S. 2011. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc Natl Acad Sci 108: 4858-4863.
52. Sved J, Bird A. 1990. The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model. Proc Natl Acad Sci 87: 4692-4696.
53. Teng G, Papavasiliou FN. 2007. Immunoglobulin somatic hypermutation. Annu Rev Genet 41: 107-120.
54. Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, et al. 2015. Tissue-based map of the human proteome. Science 347: 1260419.
55. Wang J, Zhuang J, Iyer S, Lin X-Y, Greven MC, Kim B-H, Moore J, Pierce BG, Dong X, Virgil D, et al. 2013. Factorbook.org: a Wiki-based database for transcription factor-binding data generated by the ENCODE consortium. Nucleic Acids Res 41: D171-D176.
56. Zhang J, Webb DM. 2004. Rapid evolution of primate antiviral enzyme APOBEC3G. Hum Mol Genet 13: 1785-1791.
57. Zhu W, Cooper DN, Zhao Q, Wang Y, Liu R, Li Q, Férec C, Wang Y, Chen JM. 2015. Concurrent nucleotide substitution mutations in the human genome are characterized by a significantly decreased transition/transversion ratio. Hum Mutat 36: 333-341.